Targeted Therapy in Melanoma - Richard D Carvajal MD

Richard D. Carvajal, MD, Director of the Experimental Therapeutics/Phase I program and Melanoma at Columbia University describes the future of targeted therapy - BRAF, MEK, and others in relation to clinical trials for metastatic melanoma at The Angeles Clinic Melanoma Education Symposium 2015 - www.theangelesclinic.org

[@ronaldhoage7245]

Hats off to a brilliant Doctor and his courageous efforts to beat this horrible disease.